Clearpoint Neuro Inc

NASDAQ CLPT

Data sourced from

and

Daily

Download Data

Clearpoint Neuro Inc Price to Book Ratio (P/B) on June 03, 2024: 4.50

Clearpoint Neuro Inc Price to Book Ratio (P/B) is 4.50 on June 03, 2024, a -12.74% change year over year. The price to book ratio compares the market price per share of a company's stock to its book value per share. It is calculated by dividing the market capitalization by the shareholders' equity minus treasury stock, divided by the number of outstanding shares. This ratio provides insights into how the market values a company relative to its book value. A ratio above 1 indicates the market values the company more than its book value, suggesting positive market sentiment.

Clearpoint Neuro Inc 52-week high Price to Book Ratio (P/B) is 9.19 on March 14, 2024, which is 103.98% above the current Price to Book Ratio (P/B).
Clearpoint Neuro Inc 52-week low Price to Book Ratio (P/B) is 4.31 on May 31, 2024, which is -4.40% below the current Price to Book Ratio (P/B).
Clearpoint Neuro Inc average Price to Book Ratio (P/B) for the last 52 weeks is 6.12.

NASDAQ: CLPT

Clearpoint Neuro Inc

CEO	Mr. Joseph Michael Burnett
IPO Date	Feb. 12, 2020
Location	United States
Headquarters	120 S. Sierra Avenue, Solana Beach, CA, United States, 92075
Employees	107
Sector	Healthcare
Industry	Medical devices

Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Key trends